相关实验视频
Updated: Jan 15, 2026

08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
15.8K
一剂量,大影响:在高风险多水症分娩中重新检查卡贝托辛
Burak Elmas1, Uğurcan Zorlu2, Gonca Türker Ergün3
1Department of Obstetrics and Gynecology, Acıbadem Maslak Hospital, Istanbul, Turkey.
概括
卡贝托辛在预防分娩后出血 (PPH) 方面比催产素或催产素-厄戈米特林更有效,对于患有孤立多水症的妇女来说. 这种子宫增生剂提供持续的子宫收缩,减少了对干预的需要.
科学领域:
- 产科和妇科 产科和妇科
- 药理学 药理学是指药理学的学科.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 产后出血 (PPH) 仍然是孕产妇死亡的主要原因.
- 由于子宫过膨胀,孤立的多水症在预防PPH方面存在独特的挑战.
- 预防性子宫增生剂对于高风险怀孕中管理PPH风险至关重要.
研究的目的:
- 为了比较卡贝托辛的疗效和安全性,催产素输注,和催产素-厄戈米特林组合用于PPH预防.
- 为了评估分离的多水综合症复杂的到期怀孕中的子宫动疗法.
- 评估不同子宫激素对流血和干预需要的影响.
主要方法:
- 对286个分离多水症的终期怀孕进行了回顾性队列研究.
- 预防性子宫激素的比较:卡伯素 (n=124),氧化素 (n=116),氧化素-人体激素 (n=46).
- 排除具有额外PPH风险因素的患者;主要结局包括血液学变化和血液损失.
主要成果:
- 与其他疗法相比,卡贝托辛的血红蛋白和血红素水平下降显著较低.
- 估计的血液损失和产后休克指数在carbetocin时更为有利.
- 在carbetocin组中观察到的二次干预较少,尽管在统计学上并不显著.
结论:
- 卡尔贝托辛在患有孤立多水症的女性中提供卓越的PPH预防.
- 卡贝托辛的持续作用减少了对额外干预的需要.
- 卡贝托辛是对子宫过膨胀高风险病例的潜在有益药物.
相关概念视频
Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
Drug Dosing: Infants and Children
253
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
253
Cardiomyopathy VII: Pre and Post Operative Nursing Management
285
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
285
Teratogenicity
4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Mitral Valve Prolapse III: Nursing Management
289
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
289
Cardiac Catheterization IV: Nursing Management
644
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
644

